28 October 2025
An innovative nano-platform based on dendrimers capable of encapsulating drugs to reduce their cardiac toxicity while improving their therapeutic efficacy.
28 October 2025
Jean-Paul Borg discusses the advances made by teams in Marseille in the fields of molecular medicine, immunotherapy and targeted therapies.
28 January 2025
HU LUCA-pi on lung cancer prevention, PEPR Santé Numérique DIGPHAT for pharmacology modeling and the SouthRock consortium, an alliance with the CRCL to combat pediatric cancers.
28 January 2025
Welcome to Elias Ventre and Quentin Marcou, who join the COMPO team, headed by Drs Benzekry and Ciccolini, as Research Associates.
28 January 2025
Thanks to the Pancreas-View tool, personalized treatment for pancreatic cancer is becoming a reality. By integrating artificial intelligence and molecular signatures, this tool promises to improve treatment efficacy and patient survival.
28 January 2025
Pancreatic cancer, one of the most aggressive cancers, is at the heart of the COMBAT-PDAC project, supported by Europe and the ANR. The aim is to personalize treatments using innovative models and identify biomarkers to improve patient survival.
28 January 2025
SouthROCK is a consortium of excellence dedicated to pediatric cancer research, bringing together 250 experts from Lyon and Marseille. Its multidisciplinary work aims to accelerate scientific advances, improve care and prevent the side effects of treatment for sick children.
28 January 2025
The Predictive Oncology team is proud to once again receive the support of the Ligue Contre le Cancer.
28 January 2025
During the event, Dr. Emilie Mamessier presented the team and its work in progress to all CRCM members, highlighting the innovative research being carried out in the fight against cancer.